Kinnate Biopharma OverviewKinnate Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KNTE.
Quarterly EBIT
-$19.10M
↑ 41.55% YoY
As of Dec 31, 2023
Annual EBIT (TTM)
-$121.38M
↓ 2.41% YoY
Trailing 12 months ending Dec 31, 2023
Kinnate Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for KNTE.
As of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023